Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation

Official title: COMPARE-VENT Feasibility Pilot Study: A Pragmatic Cluster Randomized Crossover Trial for Ventilation Strategies and Hemodynamic Impact in Critically Ill Patients With Cardiovascular Disease

Run by Mayo Clinic · NCT07656259 · Data updated 2026-11-12

This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment75 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedFebruary 28, 2027
Study endsJune 30, 2027
Registry record updatedAugust 10, 2026
Trial IDNCT07656259 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with cardiac ICU admission requiring invasive ventilation for more than 12 hours, including those with cardiogenic shock, reduced ejection fraction, or right heart dysfunction.

Probably not a fit

Patients with very short expected ventilation duration (<12 hours), severe COPD or ARDS without pulmonary edema, or those on home ventilation or ECMO may not benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility pilot investigates two ventilation strategies—volume-controlled and pressure-controlled modes—in adults admitted to a cardiac ICU who require invasive mechanical ventilation for more than 12 hours. The study aims to assess feasibility and gather exploratory data on how these modes affect patient-ventilator interaction, sedation needs, and hemodynamics in the setting of cardiogenic disease and varying degrees of heart failure or shock. Participants may belong to predefined subgroups such as cardiogenic shock stages, use of mechanical circulatory support, reduced ejection fraction, right ventricular dysfunction, or pulmonary hypertension. The trial is led by Mayo Clinic and conducted at the Mayo Clinic in Rochester, Minnesota, without listed collaborators. Outcomes will inform whether a larger, definitive comparison is warranted in this high-risk population.

Why it matters

Potential benefit: If feasible and favorable, selecting the optimal ventilation mode could improve hemodynamics and comfort, potentially reducing complications and length of ICU stay.

How similar studies have gone: Prior data on ventilator modes in mixed critical care populations suggest mode choice can impact comfort and favor some hemodynamic profiles, but evidence is limited in cardio-cardiac ICU patients; this remains relatively novel in this specific group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Eligible adults ≥ 18 years of age admitted to the cardiac ICU with need for invasive mechanical ventilation of expected duration \>12 hours.

Pre-Specified Subgroups for exploratory outcomes:

1. SCAI Stages C-E Cardiogenic Shock
2. Mechanical circulatory support use, including intra-aortic balloon pumps and microaxial flow pumps, including Impella CP, RP Impella Flex, and Impella 5.5 devices
3. Heart failure with reduced ejection fraction: LVEF \<40% or;
4. Moderate to severe RV systolic dysfunction or;
5. Moderate to severe Pulmonary hypertension, as defined by ACC/AHA/ESC guidelines

Exclusion Criteria:

1. Expected duration of intubation \<12 hours.
2. Severe COPD, bronchopleural fistulas, or severe ARDS (Berlin criteria P/F \<100, in the absence of pulmonary edema)
3. Home ventilator or chronic tracheostomy.
4. Pregnant, incarcerated, patients or those receiving extracorporeal membrane oxygenation

Where it's running

  • Mayo Clinic, 1216 Second Street SW
    Rochester, Minnesota, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.